Literature DB >> 10608079

Chemical structure, molecular conformation, and bioactivity of endotoxins.

U Seydel1, A B Schromm, R Blunck, K Brandenburg.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10608079     DOI: 10.1159/000058754

Source DB:  PubMed          Journal:  Chem Immunol        ISSN: 0079-6034


× No keyword cloud information.
  20 in total

1.  Identification of peptides that neutralize bacterial endotoxins using beta-hairpin conformationally restricted libraries.

Authors:  H González-Navarro; P Mora; M Pastor; L Serrano; I Mingarro; E Pérez-Payá
Journal:  Mol Divers       Date:  2000       Impact factor: 2.943

2.  Natural phosphoryl and acyl variants of lipid A from Neisseria meningitidis strain 89I differentially induce tumor necrosis factor-alpha in human monocytes.

Authors:  Constance M John; Mingfeng Liu; Gary A Jarvis
Journal:  J Biol Chem       Date:  2009-06-15       Impact factor: 5.157

3.  Determination of the antibacterial and lipopolysaccharide-neutralizing regions of guinea pig neutrophil cathelicidin peptide CAP11.

Authors:  Daiju Okuda; Shin Yomogida; Hiroshi Tamura; Isao Nagaoka
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

Review 4.  Outer Membrane Lipid Secretion and the Innate Immune Response to Gram-Negative Bacteria.

Authors:  Nicole P Giordano; Melina B Cian; Zachary D Dalebroux
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 5.  Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis.

Authors:  Roland Nau; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

6.  Bacterial lipopolysaccharide promotes destabilization of lung surfactant-like films.

Authors:  Olga Cañadas; Kevin M W Keough; Cristina Casals
Journal:  Biophys J       Date:  2011-01-05       Impact factor: 4.033

7.  Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway.

Authors:  Susu M Zughaier; Yih-Ling Tzeng; Shanta M Zimmer; Anup Datta; Russell W Carlson; David S Stephens
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues.

Authors:  Isao Nagaoka; Satoko Hirota; François Niyonsaba; Michimasa Hirata; Yoshiyuki Adachi; Hiroshi Tamura; Shigenori Tanaka; Didier Heumann
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

9.  Structural and biological diversity of lipopolysaccharides from Burkholderia pseudomallei and Burkholderia thailandensis.

Authors:  Vidhya Novem; Guanghou Shui; Dongling Wang; Anne K Bendt; Siew Hoon Sim; Yichun Liu; Tuck Weng Thong; Suppiah Paramalingam Sivalingam; Eng Eong Ooi; Markus R Wenk; Gladys Tan
Journal:  Clin Vaccine Immunol       Date:  2009-08-19

10.  Evidence of a specific interaction between new synthetic antisepsis agents and CD14.

Authors:  Matteo Piazza; Liping Yu; Athmane Teghanemt; Theresa Gioannini; Jerrold Weiss; Francesco Peri
Journal:  Biochemistry       Date:  2009-12-29       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.